Eli Lilly’s top drug last year is softening. But it may not matter for the stock

Sales of some Eli Lilly drugs — including its best-selling product last year — appear to be softening, according to Wall Street analysts. But that might not be enough to stop its stock from climbing higher. Prescription data for multiple Eli Lilly drugs — especially type-2 diabetes treatment Trulicity — points to weaker trends in … Read more

Weight loss, diabetes drugs not linked to suicidal thoughts: EU probe

Boxes of Wegovy made by Novo Nordisk are seen at a pharmacy in London, Britain March 8, 2024.  Hollie Adams | Reuters European Union drug regulators found no evidence that highly popular weight loss and diabetes drugs such as Wegovy and Ozempic are linked to an increased risk of suicidal thoughts and self-injury, the regulator … Read more

Moderna halts Kenya vaccine plant plans as Covid shot demand plunges

A nurse prepares a dose of Moderna Covid-19 vaccine at Oltepesi Dispensary in Kajiado, Kenya, on September 9, 2021. Patrick Meinhardt | AFP | Getty Images Moderna on Thursday said it has paused plans to build a vaccine manufacturing site in Kenya after a steep drop in demand for its Covid vaccines. The biotech company … Read more

Pfizer RSV vaccine may protect high-risk adults ages 18-59

Respiratory syncytial virus – viral vaccine under research Hailshadow | Istock | Getty Images A vaccine from Pfizer showed the potential to protect adults ages 18 to 59 who are at increased risk of getting severely sick from respiratory syncytial virus in a late stage clinical trial, the company said Tuesday. The initial data suggests … Read more

CVS drug plans will cover OTC birth control pill Opill

In this photo illustration, a package of Opill is displayed on March 22, 2024 in San Anselmo, California.  Justin Sullivan | Getty Images CVS Health on Thursday said its drug plans will cover the first over-the-counter birth control pill in the U.S. at no cost for many health plan sponsors, a decision that could open … Read more

Drug similar to Ozempic slowed Parkinson’s disease in small trial

The coronal view of a human brain of a patient suffering from Parkinson’s disease Sherbrooke Connectivity Imaging Lab | Getty Images A highly popular class of drugs for diabetes and obesity is showing early potential to help patients with Parkinson’s disease, too.  An older diabetes treatment called lixisenatide helped slow the progression of motor disability … Read more

Health insurer stocks slide as Medicare Advantage rates disappoint

Signage is displayed on a Humana Inc. office building in Louisville, Kentucky, U.S., on Saturday, Feb. 2, 2019. Humana is scheduled to release earnings figures on February 6. Luke Sharrett | Bloomberg | Getty Images Shares of U.S. health insurers fell on Tuesday after the Biden administration didn’t boost payments for private Medicare plans as … Read more

Walgreens (WBA) earnings Q2 2024

A person rides past a Walgreens truck, owned by the Walgreens Boots Alliance, Inc., in Manhattan, New York City, U.S., November 26, 2021.  Andrew Kelly | Reuters Walgreens on Thursday reported fiscal second-quarter sales that beat Wall Street’s expectations, but lowered the high end of its full-year adjusted earnings outlook in part due to a … Read more

Altimmune weight loss drug minimized muscle mass loss in trial

Altimmune on Wednesday said its experimental drug helped patients shed weight but also minimized the loss of muscle mass in a midstage trial, a finding that could set it apart in a potentially crowded market. Altimmune is one of several smaller biotech companies that are pushing to compete directly with Novo Nordisk and Eli Lilly … Read more

Moderna moves three vaccines into final stage trials

Nikos Pekiaridis | Lightrocket | Getty Images Moderna has more to offer beyond its Covid vaccine. The biotech company Wednesday announced positive clinical trial data on three experimental vaccines against other viruses. The company is moving those shots to final stage studies, it said. The update brings Moderna a step closer to having multiple products … Read more